Comprehensive Study Guide: Eukaryotic and Prokaryotic Transcription, Gene Regulation, and Molecular Analysis Techniques

Comparison of Prokaryotic and Eukaryotic Gene Regulation

• Prokaryotic Gene Regulation Mechanisms:

  • Gene expression in prokaryotes is controlled by simple regulatory mechanisms that manage transcription using a single RNA polymerase species.

  • A family of target-recognizing factors called $\sigma$ (sigma) factors (such as $\sigma^{70}$) recognize two conserved promoter elements located at the $\text{-10}$ and $\text{-35}$ (or $\text{-30}$) positions relative to the transcription initiation site ($+1$).

  • The $\sigma$ factor recruits and loads RNA polymerase directly onto the transcription start site ($+1$) to initiate RNA synthesis.

  • Direct transcriptional activators and repressors regulate the physical loading and release of RNA polymerase at the promoter.

  • Transcription and translation occur simultaneously within the cytoplasm (coupled transcription-translation).

• Eukaryotic Gene Regulation Mechanisms:

  • Eukaryotes utilize three distinct RNA polymerases ($\text{RNA Pol I}$, $\text{RNA Pol II}$, and $\text{RNA Pol III}$).

  • The primary purpose of eukaryotic gene control is executing precise developmental and tissue-specific programs to ensure that correct genes are expressed in specific cell types at specified developmental times.

  • General Transcription Factors (GTFs) participate in an elaborate recognition sequence of core promoter elements, assembling a pre-initiation complex (PIC) before loading RNA polymerase II.

  • Eukaryotic gene regulation employs an intricate network of activators and repressors controlling the loading, release, downstream pausing, and elongation travel of RNA polymerase II.

  • Eukaryotic transcription factors are modulated by complex signal transduction networks and non-coding RNAs.

  • Expression is influenced by long-distance regulatory elements acting over substantial sequence distances, known as enhancers and silencers.

  • Gene expression is tightly governed by local chromatin structure at the gene locus (epigenetic control).

  • Transcription is spatially compartmentalized within the cell nucleus; synthesized pre-RNA undergoes modification and processing before export to the cytoplasm for translation by ribosomes.

The Escherichia coli lac Operon: A Model Prokaryotic Regulatory System

• Operon Architecture and Components:

  • The $E.\,coli$ $lac$ operon provides a classic model of regulated prokaryotic gene transcription.

  • Promoter: Serves as the binding site for RNA polymerase. RNA polymerase binds at the $\text{-10}$ sequence, while the $\sigma^{70}$ factor interacts with promoter elements ($\text{-10}$ and $\text{-30}$ elements function as basal elements present in promoters).

  • CAP Site: A regulatory sequence located upstream of the promoter that binds the Catabolite Activator Protein (CAP).

  • Operator: A sequence overlapping/downstream of the promoter and transcription initiation site ($+1$) that binds the $lac$ repressor protein.

  • Structural Gene: $lacZ$, which encodes the enzyme $\beta$-galactosidase.

• Activator and Repressor Control:

  • Catabolite Activator Protein (CAP): CAP acts as an activator. In the absence of glucose, cellular levels of cyclic AMP ($\text{cAMP}$) rise. $\text{cAMP}$ binds CAP to activate it. Activated CAP binds the CAP site upstream of the promoter, stimulating the direct recruitment of RNA polymerase.

  • lac Repressor: The $lac$ repressor binds the operator sequence, physically preventing RNA polymerase from transcribing the gene.

• Functional States of the lac Operon:

  • State 1: Absence of Lactose, Presence of Glucose (Low $\text{cAMP}$): $\text{cAMP}$ levels are low, leaving CAP inactive (unbound). The $lac$ repressor remains bound to the operator. Outcome: No $lacZ$ $\text{mRNA}$ transcription occurs.

  • State 2: Presence of Lactose, Presence of Glucose (Low $\text{cAMP}$): Lactose molecules bind the $lac$ repressor, inducing a conformational change that prevents it from binding the operator. CAP remains inactive due to low $\text{cAMP}$. RNA polymerase binds the promoter weakly without activator aid. Outcome: Low (basal) transcription occurs.

  • State 3: Presence of Lactose, Absence of Glucose (High $\text{cAMP}$): Lactose prevents $lac$ repressor binding to the operator. High $\text{cAMP}$ levels allow CAP to form a $\text{cAMP-CAP}$ complex, which binds the CAP site and recruits $\sigma^{70}$-RNA polymerase to the promoter. Outcome: High levels of $lacZ$ $\text{mRNA}$ transcription occur.

Eukaryotic Chromatin Structure and Epigenetic Regulation

• Chromatin and Epigenetics:

  • Eukaryotic transcription occurs on genomic DNA wrapped around histone proteins into chromatin fibers.

  • For a gene to become activated and transcribed, dense chromatin structure must open (decondense) to permit transcription machinery access.

  • Chromatin-mediated structural remodeling represents a fundamental eukaryotic regulatory strategy, forming an essential component of epigenetic regulation.

• Cellular Differentiation Programs:

  • Multicellular development relies on cell lineage-specific chromatin states that establish specialized tissue identities across embryonic layers:

  • Ectoderm (External Layer): Gives rise to epidermal skin cells, brain neurons, and pigment cells.

  • Mesoderm (Middle Layer): Generates cardiac muscle cells, skeletal muscle cells, renal tubule cells, red blood cells, and gut smooth muscle cells.

  • Endoderm (Internal Layer): Gives rise to lung alveolar cells, thyroid cells, and pancreatic/digestive cells.

• Structural Classes of Chromatin:

  • Heterochromatin (hetero = different):

  • Densely packed chromosomal regions rich in repetitive DNA structures (transposons, centromeres, and telomeres).

  • Inaccessible to transcription factors and RNA polymerase machinery.

  • Contains transcriptionally silent, inactive genes.

  • Appears as dense dark regions ($\text{H}$) in nuclear electron micrographs.

  • Euchromatin (eu = true):

  • Less dense, open chromatin regions.

  • Accessible to general transcription factors, activators, and polymerases.

  • Contains transcriptionally active genes undergoing mRNA synthesis.

  • Appears as pale, light regions ($\text{E}$) in nuclear electron micrographs.

• Chromatin Remodeling Mechanisms:

  • In closed chromatin ("Gene Off"), nucleosomes are densely packed over promoter regions.

  • Pioneer transcription factors bind target sites within condensed chromatin and recruit chromatin co-activators.

  • Histone modifications, such as acetylation ($\text{Ac}$) and methylation ($\text{Me}$), alter histone-DNA interactions to open chromatin structures ("Gene On").

  • Repressors can reverse these modifications to re-condense chromatin and silence gene activity.

Eukaryotic RNA Polymerases and Structural Features

• The Three Eukaryotic RNA Polymerase Classes:

  • RNA Polymerase I ($\text{RNA Pol I}$): Transcribes ribosomal RNA ($\text{rRNA}$) genes. Uses General Transcription Factors labeled as $\text{TFI}$ (such as $\text{TFIA}$ and $\text{TFIB}$).

  • RNA Polymerase II ($\text{RNA Pol II}$): Transcribes all protein-coding genes ($\text{mRNA}$) and non-coding RNAs. Uses General Transcription Factors labeled as $\text{TFII}$ ($\text{TFIIA}$, $\text{TFIIB}$, $\text{TFIID}$, $\text{TFIIE}$, and $\text{TFIIH}$).

  • RNA Polymerase III ($\text{RNA Pol III}$): Transcribes transfer RNAs ($\text{tRNA}$), $\text{5S rRNA}$, and small nuclear RNAs. Uses General Transcription Factors labeled as $\text{TFIII}$ (such as $\text{TFIIIB}$ and $\text{TFIIIS}$).

• Structure of RNA Polymerase II:

  • Resolved at high resolution via X-ray crystallography in yeast ($\text{Saccharomyces cerevisiae}$).

  • Composed of $12$ distinct polypeptide subunits designated $\text{RPB1}$ through $\text{RPB12}$.

  • Subunits exhibit structural homology to bacterial RNA polymerase subunits; eukaryotic $\text{RPB1}$ and $\text{RPB2}$ subunits correspond structurally and functionally to bacterial $\beta'$ and $\beta$ subunits, respectively.

  • Clamp Domain: Located on the $\text{RPB1}$ subunit, accommodates the double-stranded DNA molecule.

  • Bridge Structural Element: Following DNA entry, the clamp domain shifts into a closed conformation maintained by the bridge element.

  • Catalytic Center: Houses the active site where RNA strand synthesis takes place using divalent magnesium ions ($\text{Mg}^{2+}$).

  • Wall Domain: Forces the template DNA strand to bend at a precise angle toward the catalytic site.

  • RNA Exit Channel: A specialized channel through which the newly synthesized RNA strand exits the enzyme complex. Extruded nascent RNA is immediately capped with $7\text{m-guanosine}$ ($7\text{-methylguanosine}$).

• Carboxy-Terminal Domain (CTD) of RPB1:

  • $\text{RNA Pol II}$ possesses a unique, unstructured Carboxy-Terminal Domain (CTD) at the tail of its $\text{RPB1}$ subunit, which is absent in $\text{RNA Pol I}$, $\text{RNA Pol III}$, and bacterial RNA polymerases.

  • Consists of tandem peptide repeats rich in Serine ($\text{Ser}$) residues.

  • Serine residues within the CTD undergo dynamic phosphorylation during the functional transition from transcription initiation to elongation.

  • Because the CTD is intrinsically unstructured, it cannot be resolved by standard X-ray crystallography.

  • Functions as a master binding scaffold for regulatory factors governing transcription initiation, promoter release, elongation, pausing, and post-transcriptional mRNA processing (capping, splicing, and polyadenylation).

Promoters and Core Elements of Eukaryotic RNA Polymerase II

• Architecture of Pol II Promoters:

  • Genes transcribed by $\text{RNA Pol II}$ are regulated by conserved core promoter elements (basal elements), promoter-proximal activator binding sites, distal enhancer/repressor sequences, and chromatin packaging.

  • Transcription initiates at a defined base termed the initiation site ($+1$), which is typically an Adenine ($\text{A}$) base on the coding strand.

• Four Primary Core Promoter Elements:

  • BRE (TFIIB Recognition Element):

  • Position: Located upstream between $\sim -37$ and $\sim -32$ relative to the start site ($+1$).

  • Sequence Motif: $\text{GGG/CCA CCGCC}$.

  • Function: Directly recognized by $\text{TFIIB}$; modulates basal promoter activity.

  • TATA Box:

  • Position: Located upstream between $\sim -31$ and $\sim -26$ relative to $+1$.

  • Sequence Motif: Highly conserved consensus sequence $\text{TATA}\frac{\text{A}}{\text{T}}\text{A}\frac{\text{A}}{\text{T}}\text{G}$.

  • Function: Prevalent in highly transcribed, tightly regulated genes; positions the pre-initiation complex.

  • Initiator (Inr):

  • Position: Spans the transcription initiation site from $\text{-2}$ to $+4$.

  • Sequence Motif: Less conserved than the TATA box. Present in some promoters lacking a TATA box.

  • Drosophila Consensus: $\text{TCA}_{+1}\frac{\text{G}}{\text{T}}\text{T}\frac{\text{T}}{\text{C}}\text{C}$.

  • Mammalian Consensus: $\text{YYAN}_{+1}\frac{\text{T}}{\text{A}}\text{YY}$ (where $\text{Y}$ represents a pyrimidine [$\text{C/T}$] and $\text{N}$ represents any base).

  • DPE (Downstream Promoter Element):

  • Position: Located downstream of the initiation site between $+28$ and $+32$.

  • Sequence Motif: $\text{A/G G A/T C A/C G/A C}$.

  • Function: Works in conjunction with $\text{Inr}$ in TATA-less promoters to direct $\text{TFIID}$ binding.

• CpG Island Promoters:

  • Found near the transcriptional initiation site of $\sim 70\%$ of vertebrate genes (such as the human $APRT$ gene encoding Adenine Phosphoribosyl Transferase).

  • Commonly located at the promoters of essential "housekeeping" genes expressed at steady, low rates.

  • $\text{CpG}$ islands are sequence stretches containing high concentrations of $\text{CG}$ dinucleotides.

  • $\text{CpG}$-rich DNA exhibits reduced nucleosome density, creating accessible, easy-to-transcribe DNA.

  • Transcription initiation at $\text{CpG}$ islands does not start at a single defined base, but rather at variable positions across the island.

  • Transcription initiates bidirectionally from $\text{CpG}$ islands; polymerases moving in the antisense direction stall and fall off DNA, while polymerases moving in the sense direction proceed through the Open Reading Frame (ORF).

Assembly of the Pre-Initiation Complex (PIC)

• Requirement for General Transcription Factors (GTFs):

  • $\text{RNA Pol II}$ cannot directly recognize core promoter sequences on its own; it requires step-by-step assembly of General Transcription Factors (GTFs) to build the Pre-Initiation Complex (PIC).

• Step-by-Step PIC Assembly Sequence:

  1. TFIID Binding: Assembly begins with the multi-protein complex $\text{TFIID}$ binding to the promoter. $\text{TFIID}$ contains TATA-Binding Protein ($\text{TBP}$) and TBP-Associated Factors ($\text{TAFs}$).

  2. TFIIA and TFIIB Recruitment: $\text{TFIIA}$ and $\text{TFIIB}$ bind $\text{TFIID}$ and neighboring DNA sequences ($\text{TFIIB}$ interacts with $\text{BRE}$).

  3. RNA Pol II and TFIIF Recruitment: $\text{RNA Pol II}$ is recruited to the promoter complex in physical association with $\text{TFIIF}$. The unphosphorylated Carboxy-Terminal Domain (CTD) of $\text{RNA Pol II}$ makes direct structural contacts with multiple GTFs.

  4. TFIIE and TFIIH Recruitment: $\text{TFIIE}$ joins the complex, recruiting $\text{TFIIH}$.

• Dual Catalytic Roles of TFIIH:

  • DNA Helicase Activity: $\text{TFIIH}$ utilizes $\text{ATP}$ hydrolysis to unwind the DNA double helix surrounding the start site, converting the closed PIC into an open complex and forming a structural "transcription bubble".

  • Protein Kinase Activity: $\text{TFIIH}$ phosphorylates Serine residues on the CTD of $\text{RNA Pol II}$, triggering promoter clearance and initiating transcription.

• Auxiliary Factors Supporting Initiation:

  • DNA Helicases: Unwind DNA strands during initiation.

  • Protein Kinases: Phosphorylate regulatory sites to release polymerases from promoter complexes.

  • Elongation Factors: Enhance processivity and movement of advancing polymerases.

  • Chromatin Remodeling Factors: Displace nucleosomes ahead of the elongation complex.

Transition from Initiation to Pausing and Elongation

• Promoter Clearance and Proximal Pausing:

  • $\text{RNA Pol II}$ initiates transcription at the $+1$ site and synthesizes a short RNA strand.

  • Initial phosphorylation of the CTD by the kinase activity of $\text{TFIIH}$ releases $\text{RNA Pol II}$ from promoter-bound GTFs.

  • Shortly after moving downstream ($\sim +30$ to $+50\,\text{bp}$), two negative elongation factors associate with $\text{RNA Pol II}$:

  • NELF (Negative Elongation Factor)

  • DSIF (DRB Sensitivity-Inducing Factor)

  • The binding of $\text{NELF}$ and $\text{DSIF}$ causes $\text{RNA Pol II}$ to enter a state of promoter-proximal pausing.

• Release into Productive Elongation:

  • A protein kinase complex called P-TEFb (Positive Transcription Elongation Factor b, composed of $\text{CDK9}$ and $\text{Cyclin T}$ / $\text{CycT}$) phosphorylates $\text{NELF}$, $\text{DSIF}$, and additional Serine residues on the CTD of $\text{RNA Pol II}$.

  • Phosphorylated $\text{NELF}$ dissociates from the complex.

  • Phosphorylated $\text{DSIF}$ undergoes a functional transition, transforming into a positive elongation factor.

  • Additional positive elongation factors associate with the polymerase complex:

  • PAF (Polymerase Associated Factor)

  • SPT6 / Spt16 (Suppressor of Ty 6/16): Aids in clearing and removing nucleosomes from DNA ahead of the elongation complex.

  • $\text{RNA Pol II}$ with a fully phosphorylated CTD is released from pausing to execute productive RNA transcript elongation.

• Bidirectional Initiation Dynamics at CpG Islands:

  • Analysis using $\text{Br-UTP}$ labeling, ChIP with anti-RNA Pol II antibodies, and high-resolution sequencing demonstrates that $\text{RNA Pol II}$ initiates bidirectionally at $\text{CpG}$ islands.

  • Transcription tracks reveal RNA peaks centered at $\sim +50\,\text{bp}$ (sense direction) and $\sim -250\,\text{bp}$ (antisense direction).

  • Equal numbers of $\text{RNA Pol II}$ molecules initiate in both directions.

  • Sense Transcripts: Pause at $\sim +50\,\text{bp}$ before receiving signaling ($\text{P-TEFb}$) to enter productive elongation through the open reading frame.

  • Antisense Transcripts: Pause at $\sim -250\,\text{bp}$ at the far edge of the $\text{CpG}$ island, fail to receive elongation factors, stall, and abortively fall off DNA without continuing.

HIV Latency and Transcriptional Regulation

• HIV Transcriptional Elongation Control:

  • Human Immunodeficiency Virus ($\text{HIV}$) exploits host eukaryotic transcriptional elongation mechanisms to govern viral latency and activation.

  • Following integration, $\text{RNA Pol II}$ initiates transcription at the viral promoter located in the Long Terminal Repeat ($\text{LTR}$).

  • $\text{RNA Pol II}$ transcribes a short $\text{5'}$ segment of viral RNA before entering promoter-proximal pausing.

  • The synthesized $\text{5'}$ terminal sequence folds into a stem-loop secondary RNA structure designated TAR (Trans-Activation Response element).

  • The $\text{TAR}$ hairpin holds $\text{RNA Pol II}$ in place and inhibits host $\text{P-TEFb}$ ($\text{CDK9/CycT}$) kinase activity, keeping viral transcription locked in a paused, latent state.

• Molecular Role of the HIV Tat Protein:

  • $\text{HIV}$ encodes a specialized regulatory protein termed Tat (Trans-Activator of Transcription).

  • Under basal conditions or host cellular stress, low-level transcript read-through leads to the production of small amounts of Tat protein.

  • Tat binds directly to the $\text{TAR}$ stem-loop structure on the nascent viral RNA.

  • Bound Tat recruits and potently activates the $\text{CDK9/CycT}$ ($\text{P-TEFb}$) kinase complex.

  • Activated $\text{P-TEFb}$ phosphorylates the CTD of $\text{RNA Pol II}$, $\text{NELF}$, and $\text{DSIF}$, releasing paused $\text{RNA Pol II}$ and stimulating rapid, full-length viral RNA elongation.

• Pathophysiological Implications:

  • This mechanism underlies HIV viral latency: the provirus remains dormant inside host immune cells until cellular stress triggers Tat synthesis.

  • Activation leads to high-rate viral replication, destroying host T-lymphocytes and destroying the host immune system.

Molecular Biology Techniques for Gene Expression Analysis

• Polymerase Chain Reaction (PCR):

  • A technique used to exponentially amplify specific target DNA fragments through repetitive thermocycling reactions in the presence of a thermostable DNA polymerase (such as Taq polymerase).

  • Thermal Cycles (Repeated $30$ times):

  1. Denaturation: Double-stranded DNA is melted into single strands at high temperature ($\text{95}^\circ\text{C}$).

  2. Annealing: Temperature is lowered to $\text{50--60}^\circ\text{C}$, allowing two synthetic primers to bind specific complementary sequences flanking the target fragment.

  3. Elongation: Temperature is raised to $\text{72}^\circ\text{C}$, where Taq polymerase synthesizes new complementary DNA strands extending from the $3'$ ends of annealed primers.

  • Yield: Amplification follows $2^n$ kinetics; starting with $1$ double-stranded DNA molecule yields $2^{30}$ ($\sim 1.07 \times 10^9$) molecules after $30$ complete cycles.

• Reverse Transcription Quantitative PCR (qRT-PCR):

  • Quantitative method used to measure specific transcript abundance in biological samples.

  • Total RNA is isolated and converted into complementary DNA (cDNA) using specific gene primers and an RNA-dependent DNA polymerase (reverse transcriptase).

  • Synthesized cDNA undergoes PCR amplification using Taq polymerase and gene-specific primers.

  • Quantifying amplified cDNA product yields an indirect measurement of corresponding $\text{mRNA}$ levels in the original sample.

• Massively Parallel DNA Sequencing and RNA-seq:

  • Sequencing methods are qualitative (determining exact genome base sequences) and/or quantitative (counting copy numbers of DNA/RNA fragments).

  • Traditional Sanger dideoxy-NTP ($\text{ddNTP}$) sequencing reads single fragments, whereas contemporary massively parallel sequencing processes billions of DNA fragments simultaneously.

• Global RNA Sequencing (RNA-seq) Protocol:

  1. Total RNA is isolated from biological samples.

  2. RNA is reverse-transcribed into cDNA using random primers and reverse transcriptase.

  3. cDNA is fragmented into small pieces ($\sim 200\,\text{bp}$).

  4. Oligonucleotide linkers are ligated to fragment ends, anchored to solid supports, and amplified into localized clonal clusters via bridge PCR.

  5. Fragments are sequenced using fluorescently tagged nucleotides ($\text{dNTPs}$), recording base incorporation cycles across clusters.

  6. High-throughput sequence reads are aligned to reference genome sequences using bioinformatics software.

  7. Aligned read counts per genomic locus are quantified and plotted to construct transcription density profiles at single-nucleotide resolution, allowing measurement of unidirectional and bidirectional transcription.

  • Antibodies and Immunological Applications:

• Immunoglobulins are produced naturally by specialized B-lymphocyte lineages against foreign antigen proteins.

• Monoclonal Antibodies: Homogeneous antibodies produced by a single isolated B-lymphocyte clone, targeting a single specific antigenic epitope.

• Polyclonal Antibodies: Heterogeneous mixtures of antibodies secreted by multiple distinct B-lymphocyte clones, recognizing multiple distinct epitopes across an antigen molecule.

• Immunofluorescence:

  • Target-specific primary antibodies bind target cellular antigens in fixed cell or tissue samples.

  • Fluorochrome-conjugated secondary antibodies bind the primary antibodies.

  • Visualized under fluorescence microscopy to map exact subcellular localization of target proteins (e.g., distinguishing lateral membrane E-cadherin from Ksp-cadherin).

• Immunoprecipitation (IP):

  • Target-specific primary antibodies are added to complex cell protein lysates.

  • Agarose or magnetic beads are introduced to bind antibody-antigen complexes.

  • Samples are centrifuged and washed to purify target antigens (and bound interacting proteins) from lysates.

  • Bound antigens are eluted and analyzed via Western Blotting.

• Chromatin Immunoprecipitation Sequencing (ChIP-seq):

  • Combines cross-linking immunoprecipitation, PCR amplification, and massively parallel sequencing to identify protein-DNA binding interactions in vivo:

    1. Living cells or tissues are treated with a membrane-permeating cross-linker (such as formaldehyde) to covalently lock protein-DNA complexes in place.

    2. Cells are lysed and sonicated to shear cellular chromatin into short fragments ($\sim 200\text{--}500\,\text{bp}$), followed by addition of target-specific antibodies (e.g., anti-RNA Pol II, anti-CTCF, anti-H3K27me3).

    3. Antibody-protein-DNA complexes are immunoprecipitated using beads.

    4. Protein-DNA cross-links are reversed, bound DNA is isolated, converted into a cDNA sequencing library, and subjected to massively parallel sequencing.

    5. Sequenced reads are mapped to reference genomes to plot binding density peaks across genomic loci.

• ChIP-seq Track Interpretations (e.g., Chromosome 22 locus containing $FBXO7$ and $SYN3$ genes):

  • CTCF Tracks: Identify localized binding peaks of the insulator protein CTCF.

  • RNA Polymerase II Tracks: Identify active promoter and transcriptionally engaged regions across target genes.

  • H3K27me3 Tracks: Map broad domains of histone H3 lysine 27 trimethylation associated with transcriptionally repressed heterochromatin.

The provided note does not cover testable theories for a university Bachelor's degree in science. The note is actually about prokaryotic and eukaryotic gene regulation, chromatin structure, transcription dynamics, and molecular biology analysis techniques.